Abstract:
A COMPOSITION CONSISTING ESSENTIALLY OF 5-AMINO-1,3-BIS (2-ETHYLHEXYL) - 5 - METHYL-HEXAHYDROPYRIMIDINE AND 2METHYL-2-NITRO-1,3-DIMORPHOLINOPROPANE IN ABOUT A 1:1 RATIO BY WEIGHT. THE COMPOSITION IS USEFUL AS A THERAPEUTIC AGENT WHEN APPLIED TOPICALLY TO THE INFECTED TISSUES OF AN ANIMAL AT A CONCENTRATION OF 1-2% IN A LOTION, CREAM OR OINTMENT.
Abstract:
A METHOD FOR REDUCING ZEARALINONE TO ZERALANOL IN WHICH THE PRODUCT CONTAINS A MAJOR AMOUNT OF THE HIGHMELTING DIASTEREOISOMER AND A MINOR AMOUNT OF THE LOWMELTING DIASTEREOISOMER OF ZEARALANOL IS DISCLOSED. ZEARALENONE IS CATALYTICALLY REDUCED WITH HYDROGEN FOR A TIME SUFFICIENT TO REDUCE THE ZEARALENONE TO ZEARALANOL IN THE PRESENCE OF A PLATINUM CATALYST AND A WEAK ACID HAVING A FIRST ACID IONIZATION CONSTANT OF FROM ABOUT 1X10**4 TO 5X10**1 IN WATER AT ABOUT 25:C. AND SAID ACID NOT BEING ITSELF REDUCED UNDER THE CONDITIONS OF THE ZEARALENONE REDUCTION.
WHERE B IS >C=O, >CHOH OR >CH2; R AND R'' CAN BE HYDROGEN, ALKYL, ACYL OR ARALKYL RADICALS; AND Y IS BROMINE. THOSE COMPOUNDS EXHIBIT ANTIBACTERIAL ACTIVITY AND CAN BE USED IN ANIMAL FEED COMPOSITIONS.